1. Home
  2. NHTC vs BTAI Comparison

NHTC vs BTAI Comparison

Compare NHTC & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$2.74

Market Cap

36.3M

Sector

Miscellaneous

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHTC
BTAI
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
49.2M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
NHTC
BTAI
Price
$2.74
$2.10
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$32.80
AVG Volume (30 Days)
73.9K
661.6K
Earning Date
11-05-2025
11-12-2025
Dividend Yield
28.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,873,000.00
$752,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$416.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$1.17
52 Week High
$6.00
$9.26

Technical Indicators

Market Signals
Indicator
NHTC
BTAI
Relative Strength Index (RSI) 38.14 51.76
Support Level $2.74 $1.82
Resistance Level $3.07 $2.33
Average True Range (ATR) 0.24 0.17
MACD 0.02 0.05
Stochastic Oscillator 18.53 62.87

Price Performance

Historical Comparison
NHTC
BTAI

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and to support active, physical and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and rest from China, Taiwan, Japan, United States and other regions.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: